Dengue virus downregulates TNFR1- and TLR3-stimulated NF-κB activation by targeting RIPK1

Front Cell Infect Microbiol. 2022 Oct 14:12:926036. doi: 10.3389/fcimb.2022.926036. eCollection 2022.

Abstract

Dengue virus (DENV) infection is the most prevalent arthropod-borne virus disease and is endemic in more than 100 countries. Several DENV proteins have been shown to target crucial human host proteins to evade innate immune responses and establish a productive infection. Here we report that the DENV NS3 protein targets RIPK1 (Receptor Interacting Protein Kinase I), a central mediator of inflammation and cell death, and decreases intracellular RIPK1 levels during DENV infection. The interaction of NS3 with RIPK1 results in the inhibition of NF-κB activation in response to TNFR or TLR3 stimulation. Also, we observed that the effects of NS3 on RIPK1 were independent of NS3 protease activity. Our data demonstrate a novel mechanism by which DENV suppresses normal cellular functions to evade host innate immune responses.

Keywords: NF-κB; NS3; dengue virus; necroptosis; ripk1.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Dengue Virus*
  • Humans
  • NF-kappa B / metabolism
  • Receptor-Interacting Protein Serine-Threonine Kinases / metabolism
  • Receptors, Tumor Necrosis Factor, Type I* / metabolism
  • Signal Transduction
  • Toll-Like Receptor 3 / metabolism

Substances

  • NF-kappa B
  • Receptor-Interacting Protein Serine-Threonine Kinases
  • Receptors, Tumor Necrosis Factor, Type I
  • RIPK1 protein, human
  • TLR3 protein, human
  • Toll-Like Receptor 3
  • TNFRSF1A protein, human